Mariam Khachatryan, Editor in Chief of OncoDaily GI at OncoDaily, shared on LinkedIn:
“It was a pleasure to host our OncoDaily webinar on ctDNA in colorectal cancer, in partnership with Natera!
We had an insightful discussion with Dr. Robert Lentz, Medical Director, GI Oncology at Natera, who shared recent advances in ctDNA, including its potential role in guiding adjuvant treatment decisions, detecting molecular recurrence, and assessing treatment response, as well as emerging evidence in neoadjuvant immunotherapy and how we might eventually integrate these findings into routine clinical practice.
I’m grateful to Dr. Lentz for sharing his expertise and valuable insights, and to Natera for this collaboration.
Thank you to Garen Balkhian and the OncoDaily Events Team for moderating the webinar, and to everyone who joined us and participated in the discussion!”
You can also read:
